Morphic to present at the 41st annual j.p. morgan healthcare conference

Waltham, mass., jan. 05, 2023 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that praveen tipirneni, m.d., president and chief executive officer, will present at the 41st annual j.p. morgan healthcare conference on wednesday, january 11, 2023 at 2:15 pm pst.
MORF Ratings Summary
MORF Quant Ranking